[F-18] RGD-K5 Positron Emission Tomography (PET) in Participants With Carotid Artery Stenosis

Summary

This trial will be the first trial for the Investigation Product (IP), \[F-18\]RGD-K5 for carotid plaque imaging and will be conducted as a Phase II trial since this compound has already been tested in humans for phase I and phase II imaging. All study results will be evaluated and analyzed in order to consider the design for future clinical trials.

Timeline

Start

2012-05

Primary completion

2013-03

Completion

2013-03

Outcome

Outcome not reported

Stopped: “Sponsor decided to develop the product in collaboration”

Drugs

Indications